Credit Suisse Lowers Pear Therapeutics' Price Target to $9 from $11, Adjusts Guidance While Awaiting Reorganization Impact; Keeps Outperform Rating
Credit Suisse Lowers Pear Therapeutics' Price Target to $9 from $11, Adjusts Guidance While Awaiting Reorganization Impact; Keeps Outperform Rating
瑞士信貸將Pear Therapeutics的目標股價從11美元下調至9美元,在等待重組影響的同時調整了指導方針;維持跑贏大盤評級
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊